Rivkin Anna reported FHTX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002035647-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 30, 2026

Published

Feb 2, 2026

Ingested by INSIDER

Nov 5, 04:19 UTC

Last re-read

Nov 5, 04:19 UTC

Extracted facts

Filer

Rivkin Anna

Role

Chief Business Officer

Transaction

Grant or awardAs filed: “A”

Asset

Foghorn Therapeutics Inc. — Stock option (right to buy)

Ticker

FHTX

Shares

165.0K

Price per share

$5.71

Value

$942,150

Execution date (reported)

Jan 30, 2026

Owned after transaction

165.0K shares

Days from execution to publication

3

Calculation

What this establishes

Rivkin Anna filed this Form 4 reporting a grant or award of FHTX on Jan 30, 2026. It became public on Feb 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Business Officer

Rivkin Annacik:0002035647

Issuer

Foghorn Therapeutics Inc.cik:0001822462

Revision history · 0

No field has changed since this record was first ingested.